Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Pharmaceuticals ETF

+ Add to Watchlist

XPH:US

123.1800 USD 0.2500 0.20%

As of 16:15:06 ET on 05/22/2015.

Snapshot for SPDR S&P Pharmaceuticals ETF (XPH)

Open: 123.2300 High - Low: 123.6200 - 122.3000 Primary Exchange: NYSE Arca
Volume: 41,775 52-Week Range: 88.5604 - 132.5500 Beta vs SPSIPHTR: 1.0019

ETF Chart for XPH

No chart data available.
  • XPH:US 123.1800
  • 1D
  • 1M
  • 1Y
122.9300
Interactive XPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XPH

SPDR Pharmaceuticals ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate as closely as possible the performance of the S&P Pharmaceuticals Select Industry Index, an equal-weighted index.

Inception Date: 2006-06-22 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XPH

NAV (on 2015-05-21) 122.9028
Assets (M) (on 2015-05-21) 1,161.4480
Shares out (M) 9.45
Market Cap (M) 1,161.04
% Premium 0.02
Average 52-Week % Premium 0.0217
Fund Leveraged N

Dividends for XPH

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2015-03-20) 0.2082
Dividend Yield (ttm) 4.94%

Performance for XPH

1-Month -5.66% 1-Year +35.66%
3-Month +0.08% 3-Year +34.44%
Year To Date +14.05% 5-Year +28.33%
Expense Ratio 0.35

Top Fund Holdings for XPH

Filing Date: 05/20/2015
Name Position Value % of Total
Horizon Pharma Plc 1,628,182 48,991,996 4.220%
Tetraphase Pharmaceuticals Inc 958,697 43,457,735 3.743%
Perrigo Co PLC 219,802 43,419,687 3.740%
Mylan NV 612,132 43,124,699 3.715%
AbbVie Inc 630,815 41,564,400 3.580%
Merck & Co Inc 650,981 39,358,311 3.390%
Akorn Inc 886,229 38,905,453 3.351%
Eli Lilly & Co 523,449 38,400,219 3.308%
Johnson & Johnson 368,722 38,199,599 3.290%
Mallinckrodt PLC 294,774 38,037,637 3.276%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil